» Articles » PMID: 2044435

Insulin Resistance, Hyperinsulinemia, Hypertriglyceridemia, and Hypertension. Parallels Between Human Disease and Rodent Models

Overview
Journal Diabetes Care
Specialty Endocrinology
Date 1991 Mar 1
PMID 2044435
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

There is considerable evidence that abnormalities of glucose, insulin, and lipoprotein metabolism occur more frequently in untreated hypertensive patients than in normotensive control subjects. More recently, it has also become apparent that similar metabolic abnormalities occur in rodent models of hypertension. One purpose of this article is to review the experimental data that have led to the above generalizations. The second goal is to address the significance of these findings, which is certainly not clear. For example, it could be argued that the relationship between high blood pressure and the associated metabolic defects is incidental. On the other hand, there is evidence that the changes in glucose, insulin, and lipoprotein metabolism may play a role in the etiology and/or clinical course of patients with high blood pressure. Although it is impossible at this point to definitively choose between these possibilities, an effort is made to marshal the evidence in support of the latter alternative.

Citing Articles

Cinnamic acid alleviates endothelial dysfunction and oxidative stress by targeting PPARδ in obesity and diabetes.

Bai Y, Tan D, Deng Q, Miao L, Wang Y, Zhou Y Chin Med. 2025; 20(1):13.

PMID: 39856769 PMC: 11760083. DOI: 10.1186/s13020-025-01064-7.


Saroglitazar suppresses KIM-1 and type IV collagen in high fat diet and low-dose streptozotocin-induced diabetic nephropathy in Wistar rats.

Ahamad R, Bhandari U, Nabi S, Sharma S Iran J Basic Med Sci. 2024; 27(11):1447-1455.

PMID: 39386240 PMC: 11459336. DOI: 10.22038/ijbms.2024.78221.16908.


Treatment with Extract Reduces Insulin Resistance, Hyperglycemia and Improves SIRT1 Expression in Type 2 Diabetic Rats.

Agrawal O, Kulkarni Y Life (Basel). 2023; 13(5).

PMID: 37240813 PMC: 10221349. DOI: 10.3390/life13051168.


Intensive Blood Pressure Control and Diabetes Mellitus Incidence for Patients with Impaired Fasting Glucose: A Secondary Analysis of SPRINT.

Lin B, Liu X, Yao S, Pan Z Int J Hypertens. 2023; 2023:7533353.

PMID: 36968629 PMC: 10036175. DOI: 10.1155/2023/7533353.


Evaluating the use of novel atherogenicity indices and insulin resistance surrogate markers in predicting the risk of coronary artery disease: a case‒control investigation with comparison to traditional biomarkers.

Mahdavi-Roshan M, Mozafarihashjin M, Shoaibinobarian N, Ghorbani Z, Salari A, Savarrakhsh A Lipids Health Dis. 2022; 21(1):126.

PMID: 36435770 PMC: 9701407. DOI: 10.1186/s12944-022-01732-9.